Invite your Peers
And receive 1 week of complimentary premium membership
Upcoming Events (0)
ORGANIZE A MEETING OR EVENT
And earn up to €300 per participant.
Sub Circles (0)
No sub circles for Bio-technology
Warburg-backed ESR eyes strategic divestments in China amid portfolio overhaul ' Private Equity Insights
People familiar with the matter said the company may sell properties individually or as a portfolio worth several billion dollars. ESR plans to appoint advisers to review options, though discussions remain preliminary and may not result in a transaction. Greater China accounted for 27% of ESR's revenue last year. The firm manages roughly $30bn of assets across the region, including logistics parks on the mainland, a data centre in Hong Kong, retail and office properties in Shanghai, and a life sciences facility. ESR also owns industrial and logistics assets across Asia and has a presence in Europe. ESR was delisted from the Hong Kong stock exchange earlier this year after being acquired by a consortium including Starwood Capital Group, Sixth Street Partners, SSW Partners, Qatar Investment Authority, Warburg Pincus, and its founders. Foreign investors have deployed close to $140bn into Chinese real estate over the past 15 years, but many are now seeking exits as the sector comes under pressure. Bloomberg reported in October that numerous global buyers are reassessing their China exposure as warehouses stand empty and asset values soften....
Mark shared this article 4d
Inaugural UROP mixer draws hundreds of students eager to gain research experience
'At MIT, we believe in the transformative power of learning by doing, and there's no better example than UROP,' says MIT President Sally Kornbluth, who attended the mixer with Provost Anantha Chandrakasan and Chancellor Melissa Nobles. 'The energy at the inaugural UROP mixer was exhilarating, and I'm delighted that students now have this easy way to explore different paths to the frontiers of research.' The event gave students the chance to explore internships and undergraduate research opportunities ' in fields ranging from artificial intelligence to the life sciences to the arts, and beyond ' all in one place, with approximately 150 researchers from labs available to discuss the projects and answer questions in real time. The offices of the Chancellor and Provost co-hosted the event, which the UROP office helped coordinate. First-year student Isabell Luo recently began a UROP project in the Living Matter lab led by Professor Rafael Gomez-Bombarelli, where she is benchmarking machine-learned interatomic potentials that simulate chemical reactions at the molecular level and exploring fine-tuning strategies to improve their accuracy. She's passionate about AI and machine learning, eco-friendly design, and entrepreneurship, and was attending the UROP mixer to find more 'real-world' projects to work on....
Mark shared this article 4d
Phil Sharp-Alnylam Fund for Emerging Scientists to support MIT biology graduate students and faculty
Posted by Mark Field from MIT in Biology, Bio-technology, and Oncology
It's no question that graduate school in fundamental research was never for the faint of heart, but academia's nationwide funding disruptions threaten not just research happening now, but the critical pipeline for the next generation of scientists. 'What's keeping me up at night is the uncertainty,' says MIT Institute Professor and Nobel laureate Phillip A. Sharp, who is also professor of biology emeritus and intramural faculty at the Koch Institute for Integrative Cancer Research. In the short term, Sharp foresees challenges in sustaining students so they can complete their degrees, postdocs to finish their professional preparation, and faculty to set up and sustain their labs. In the long term, the impact becomes potentially existential ' fewer people pursuing academia now means fewer advancements in the decades to come. So, when Sharp was looped into discussions about a gift in his honor, he knew exactly where it should be directed. Established this year thanks to a generous donation from Alnylam Pharmaceuticals, the Phil Sharp-Alnylam Fund for Emerging Scientists will support graduate students and faculty within life sciences....
Mark shared this article 24d
Apollo partners with 8VC to launch multibillion-dollar hybrid capital platform for growth tech firms ' Private Equity Insights
The partnership will leverage Apollo's hybrid business, a fast-growing division that provides structured and asset-backed capital solutions blending private credit and equity, to support capital-intensive firms across sectors such as aerospace, energy, life sciences, logistics, and advanced manufacturing. Matt Nord, Co-Head of Equity and Head of Hybrid at Apollo, said the collaboration addresses a funding gap in the market. 'There is a growing need for creative, non-dilutive capital to support companies driving industrial innovation,' he said, adding that Apollo's hybrid approach unlocks 'large pools of capital for transformative businesses.' The initiative will back companies developing large-scale digital and physical infrastructure, an area often underserved by traditional growth equity and venture investors. Apollo's hybrid platform has raised $7bn this year and now oversees around $75bn in assets, making it the firm's fastest-growing business line. The new platform expands Apollo's strategy to bridge institutional capital with private market innovation, following earlier partnerships such as its tie-up with Cadma Capital, which will also participate in the venture....
Mark shared this article 1m